Detalles de la búsqueda
1.
Pathological complete remission of relapsed tumor by photo-activating antibody-mimetic drug conjugate treatment.
Cancer Sci
; 113(12): 4350-4362, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36121618
2.
Antibody mimetic drug conjugate manufactured by high-yield Escherichia coli expression and non-covalent binding system.
Protein Expr Purif
; 192: 106043, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34973460
3.
Serologic Survey of IgG Against SARS-CoV-2 Among Hospital Visitors Without a History of SARS-CoV-2 Infection in Tokyo, 2020-2021.
J Epidemiol
; 32(2): 105-111, 2022 02 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34776499
4.
Modeling and predicting individual variation in COVID-19 vaccine-elicited antibody response in the general population.
PLOS Digit Health
; 3(5): e0000497, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38701055
5.
Association of systemic adverse reaction patterns with long-term dynamics of humoral and cellular immunity after coronavirus disease 2019 third vaccination.
Sci Rep
; 13(1): 9264, 2023 06 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37286720
6.
Five doses of the mRNA vaccination potentially suppress ancestral-strain stimulated SARS-CoV2-specific cellular immunity: a cohort study from the Fukushima vaccination community survey, Japan.
Front Immunol
; 14: 1240425, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37662950
7.
Antibody and T-Cell Responses against SARS-CoV-2 after Booster Vaccination in Patients on Dialysis: A Prospective Observational Study.
Vaccines (Basel)
; 11(2)2023 Jan 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-36851137
8.
Varying Cellular Immune Response against SARS-CoV-2 after the Booster Vaccination: A Cohort Study from Fukushima Vaccination Community Survey, Japan.
Vaccines (Basel)
; 11(5)2023 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37243024
9.
Antibody Profiling of Microbial Antigens in the Blood of COVID-19 mRNA Vaccine Recipients Using Microbial Protein Microarrays.
Vaccines (Basel)
; 11(11)2023 Nov 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38006026
10.
Factors associated with anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein antibody titer and neutralizing activity among healthcare workers following vaccination with the BNT162b2 vaccine.
PLoS One
; 17(6): e0269917, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35687563
11.
Peak IgG antibody titers against SARS-CoV-2 spike protein following immunization with the Pfizer/BioNTech BNT162b2 vaccine.
Fukushima J Med Sci
; 68(1): 67-70, 2022 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35228456
12.
Waning of Humoral Immunity and the Influencing Factors after BNT162b2 Vaccination: A Cohort Study with a Latent Growth Curve Model in Fukushima.
Vaccines (Basel)
; 10(12)2022 Nov 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-36560417
13.
The serological diversity of serum IgG/IgA/IgM against SARS-CoV-2 nucleoprotein, spike, and receptor-binding domain and neutralizing antibodies in patients with COVID-19 in Japan.
Health Sci Rep
; 5(3): e572, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35509410
14.
Factors Associated with COVID-19 Vaccine Booster Hesitancy: A Retrospective Cohort Study, Fukushima Vaccination Community Survey.
Vaccines (Basel)
; 10(4)2022 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-35455264
15.
Humoral immunity after second dose of BNT162b2 vaccine in Japanese communities: an observational cross-sectional study, Fukushima Vaccination Community Survey.
Sci Rep
; 12(1): 18929, 2022 11 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36344597
Resultados
1 -
15
de 15
1
Próxima >
>>